Beneficient filings document the regulatory record for a Nevada financial services company that provides alternative-asset exit opportunities, primary capital solutions, and related trust and custody services. Its disclosures cover Class A common stock, warrants, convertible preferred stock, customized trust vehicles, limited partner interests, and securities issued in primary capital transactions.
The company’s SEC filings include 8-K reports on operating results, unregistered equity issuances, debt agreements and repayments, litigation settlement matters, and other material events. Proxy materials document annual meeting proposals, shareholder voting results, incentive-plan amendments, board and governance matters, while periodic and exhibit disclosures provide additional information on financial condition, risk factors, and capital structure.
Beneficient major holder Mack Hicks and Hicks Holdings Operating, LLC filed Amendment No. 2 to Schedule 13D, reporting beneficial ownership of 11,712,675 Class A shares, or 81.2% of the class, including shares issuable from Class B stock as of April 13, 2026.
The amendment details a prior Limited Conversion, where Hicks Holdings converted about $48 million of BCH Preferred A-1 Unit Accounts into BCH Class S Ordinary Units at $0.52 per unit, then exchanged them for 92,485,639 Class A shares. These “Conversion Shares” are subject to possible future forfeiture based on the Average Closing Price on January 1, 2028 and are locked up under a voting and lock-up agreement until October 1, 2028.
The filing also describes a Credit Agreement where the issuer repaid about $27.5 million of loan principal early. Remaining $1.66 million of interest and fees will be settled through issuance of 149,904 Class A shares valued at $572,588, plus scheduled cash payments of $1,000,000 and $94,365.
Beneficient director and 10% owner Mack H. Hicks filed an initial statement of indirect holdings in the company’s common stock. Entities associated with him report 149,904 Class A shares through HH-BDH, LLC and 11,560,705 Class A shares through Hicks Holdings Operating LLC. Hicks Holdings also holds 2,066 Class B shares, each convertible into one Class A share. Mr. Hicks is the sole member of these entities and can vote and direct the disposition of their shares, but he disclaims beneficial ownership beyond his pecuniary interest.
Beneficient files a prospectus supplement and updates its registration to cover 71,017,840 shares of Class A Common Stock. The supplement incorporates an April 8, 2026 Form 8-K describing a primary capital transaction that issued 875,214 shares of Series B-10 Resettable Convertible Preferred Stock convertible into Class A shares under resettable terms.
The Series B-10 has an initial conversion price of $3.5479, a floor of $1.2418, a maximum of 7,047,947 Class A shares issuable upon conversion, and ownership/Exchange Cap limits including a 4.99% beneficial ownership cap. The prospectus supplement incorporates the 8-K and related certificate of designation.
Beneficient entered a GP primary capital transaction tied to an $8.75 million interest in Quartus AI Fund LP, issuing 875,214 shares of new Series B-10 Resettable Convertible Preferred Stock in a private offering under Section 4(a)(2) and Regulation D. The Series B-10 is initially convertible into Class A common stock at $3.5479 per share, subject to monthly volume-weighted average price resets, with a floor of $1.2418 and a cap at the initial price, and up to 7,047,947 Class A shares may ultimately be issued.
The company records an unrealized gain of about $1.2 million tied to its pro rata interest in the fund’s existing portfolio and expects ExAlt loan collateral to rise by approximately $9.77 million, which is also projected to add about $9.77 million of tangible book value attributable to public stockholders. The Series B-10 pays dividends on an as-converted basis, is generally non-voting, ranks pari passu with common stock and prior B-series preferred, and is junior to Series A preferred and all debt. Conversions are constrained by a 4.99% beneficial ownership limit and a Nasdaq Exchange Cap, so Beneficient plans to seek shareholder approval via a proxy to permit additional Class A issuances. Mandatory conversion is scheduled around the fifth anniversary, subject to SEC filing compliance or an effective resale registration statement.
Beneficient files a prospectus supplement registering 71,017,840 shares of Class A Common Stock. The supplement incorporates a Form 8-K dated March 27, 2026, which reports approval of a First Amendment to the Beneficient 2023 Long‑Term Incentive Plan that became effective on March 27, 2026.
The Amendment adds 1,000,000 authorized shares and sets an automatic quarterly Adjustment Date to increase Authorized Shares so the Plan equals the lesser of 200,000,000 shares and 1,000,000 plus 15% of outstanding Common Stock. At the Annual Meeting, 13,261,279 shares of Class A and 2,066 shares of Class B were present, representing approximately 91.7% of voting power. The supplement states Class A last sale price was $3.82 per share and warrants $0.0103 on April 6, 2026.
Beneficient reported results of its 2026 annual meeting of stockholders. Stockholders approved an amendment to the Beneficient 2023 Long Term Incentive Plan, increasing the shares of Class A common stock reserved for equity awards; the amendment became effective on March 27, 2026. Three Class A directors – Peter T. Cangany, Patrick J. Donegan, and Karen J. Wendel – were reelected, and Weaver and Tidwell, LLP was ratified as independent registered public accounting firm for the fiscal year ending March 31, 2026. Shares representing approximately 91.7% of total voting power as of the February 13, 2026 record date were present or represented by proxy.
Beneficient is calling a virtual annual meeting on March 27, 2026 to vote on three items: electing three Class A directors, ratifying Weaver and Tidwell, LLP as auditor for the year ending March 31, 2026, and approving an amendment to the 2023 Long Term Incentive Plan to increase Class A common stock reserved for awards.
Holders of 14,183,822 Class A shares and 29,908 Class B shares as of February 13, 2026 may vote, with Class B carrying ten votes per share. The proxy details a prior 8‑for‑1 reverse stock split that helped restore Nasdaq Capital Market compliance and describes the company’s dual-class governance and board committee structure.
The filing also summarizes extensive litigation developments, including a $55.3 million equity-awards arbitration now confirmed on appeal, a $34.5 million GWG-related settlement fully funded by insurance, several other settled or pending suits, and notes that certain settlements have largely exhausted available insurance coverage for some ongoing legal matters.
Beneficient registers 71,017,840 shares of Class A common stock in a prospectus supplement to its Form S-1. The supplement incorporates a Form 8-K dated March 12, 2026, and updates disclosure in the January 2, 2026 prospectus.
The Form 8-K describes an amendment to a credit agreement under which the company issued 149,904 shares to HH-BDH to satisfy $572,588 of accrued interest and fees, and agreed to deferred cash payments of $94,365 (payable March 31, 2026) and $1,000,000 (payable following September 30, 2026). The amendment grants HH-BDH piggyback registration rights for the issued shares. The company also appointed Mack Hicks to the board; Mr. Hicks is affiliated with Hicks Holdings and HH-BDH.
Beneficient amended its credit arrangements with HH-BDH on March 10, 2026 to settle the remaining $1.66 million of interest and fees under a prior credit agreement. The company will issue 149,904 Class A shares valued at $572,588 and pay $1,000,000 in cash after September 30, 2026, plus $94,365 after March 31, 2026. HH-BDH also received piggyback registration rights on these shares. The same day, the board appointed Mack Hicks, managing member of Hicks Holdings and an affiliate of HH-BDH, as a director pursuant to an existing stockholders agreement. As of March 11, 2026, HH-BDH held 11,710,609 Class A shares, reflecting a significant related-party relationship.
Beneficient files a prospectus supplement registering 71,017,840 shares of Class A common stock. The supplement incorporates the Company’s Form 10-Q for the quarter ended December 31, 2025 and updates the prior S-1 prospectus.
The 10-Q discloses cash and cash equivalents of $7.9 million as of December 31, 2025 (approximately $2.5 million as of January 31, 2026), consolidation of Customer ExAlt Trusts, a confirmed equity arbitration award of $62.8 million, related-party debt and events of default under the HCLP Loan Agreement, and a 1-for-8 reverse stock split effective December 15, 2025. The supplement notes an available SEPA facility up to $250.0 million with approximately $240.7 million remaining available under its terms.